Author: John Meady

FB Nasdaq FB Facebook
Finance

Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)

Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) major shareholder Sabby Management, Llc acquired 16,203 shares of Celsus Therapeutics PLC stock in a transaction dated Thursday, March 27th. The shares were purchased at an average price of $6.66 per share, for a total transaction of $107,911.98. Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock performance was -5.24% in last session and finished the day at $6.15. Traded volume was 35.9K … Continue reading Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)

John Meady
Finance

Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ocera Therapeutics Inc (NASDAQ:OCRX) is a company with one main value driver, OCR002. Financially, the company is now sitting on $47.2 M and will be spending $30M in the 2014 financial year. It has about one year in cash. Last year, it spent $3.5M in R&D and these costs are set to increase as it ramps up the Phase 2 trials for OCR002. Ocera Therapeutics … Continue reading Biotech Decliners: Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech, Inc. (OTCMKTS:MRNA), CorMedix Inc. (NYSEMKT:CRMD), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

John Meady
Finance

Utilities Active Runners: Companhia Energetica Minas Gerais (ADR) (NYSE:CIG), AES Corp (NYSE:AES), Exelon Corporation (NYSE:EXC), PG&E Corporation (NYSE:PCG)

Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) had its stock coverage assumed at Goldman Sachs Group Inc (NYSE:GS). The firm assigned buy rating on the stock. That positive rating of the stock came hot on the heels of the upgrade from Zacks, where analysts at Zacks assigned neutral on the stock from underperform. Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) stock performance was 0.89% in last session … Continue reading Utilities Active Runners: Companhia Energetica Minas Gerais (ADR) (NYSE:CIG), AES Corp (NYSE:AES), Exelon Corporation (NYSE:EXC), PG&E Corporation (NYSE:PCG)

John Meady
BBRY NASDAQ BBRY Blackberry
Diversified Tech, Internet, Mobile

BlackBerry’s Q4 Loss Narrower than Expected

BlackBerry (BBRY, BB.TO) reported a Q4 adjusted loss of $0.08 per share, better than expectations of a loss of $0.54 per share, if comparable. Revenue was $976 million, down 64% from $2.7 billion in the year ago quarter, and below the analyst consensus of $1.2 billion on Capital IQ. During Q4, the company recognized hardware revenue on approximately 1.3 million BlackBerry smartphones compared to approximately … Continue reading BlackBerry’s Q4 Loss Narrower than Expected

John Meady
Finance

Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the last session and the average volume of the stock remained … Continue reading Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

John Meady
Diversified Tech

NovaBay Pharmaceuticals Tumbles 9% in After Hours; Guess (GES) Down as Well

NovaBay Pharmaceuticals (NYSEMKT:NBY) is lower in late trading after the clinical-stage biopharmaceutical company said late Wednesday that it intends to offer shares of its common stock and warrants in an underwritten public offering. Shares are down 8.73% at $1.15, with a 52-week range of $0.76 – $2.03. The company intends to use the net proceeds from this offering for working capital and general corporate purposes, … Continue reading NovaBay Pharmaceuticals Tumbles 9% in After Hours; Guess (GES) Down as Well

John Meady